Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Short-term Investments (2022 - 2023)

PROCEPT BioRobotics has reported Short-term Investments over the past 2 years, most recently at $777000.0 for Q3 2023.

  • Quarterly results put Short-term Investments at $777000.0 for Q3 2023, changed N/A from a year ago — trailing twelve months through Sep 2023 was $777000.0 (changed N/A YoY), and the annual figure for FY2022 was $777000.0, changed.
  • Short-term Investments for Q3 2023 was $777000.0 at PROCEPT BioRobotics, roughly flat from $777000.0 in the prior quarter.
  • Over the last five years, Short-term Investments for PRCT hit a ceiling of $777000.0 in Q4 2022 and a floor of $777000.0 in Q4 2022.